Inhibition of Hepatic Fibrogenesis: A Review of Pharmacologic Candidates

References

• Gressner A M. Liver fibrosis: perspectives in pathobiochemical research and clinical outlook. Eur J Clin Chem Biochem 1991; 29: 293–311
   PubMedGoogle Scholar
• Bissell D M. Lipocyte activation and hepatic fibrosis. Gastroenterology 1992; 102: 1803–5
   PubMed Web of Science ®Google Scholar
• Bissell D M, Friedman S L, Mather J J, Roll F G. Connective tissue biology and hepatic fibrosis: report of a conference. Hepatology 1990; 11: 488–98
   PubMed Web of Science ®Google Scholar
• Bissell D M (1992) Pathophysiology of hepatic fibrosis: current progress. Proceedings of International Falk Symposium, Molecular and Cell Biology of Liver Fibrogenesis, MarburgGermany, Jan 22–23, 1992, A M Gressner, G Ramadori. Kluwer Academic Publishers, LancasterEngland, 7–11
   Google Scholar
• Clement B, Loreal O, Rescan P-Y, (1992) Cellular origin of the hepatic matrix. Proceedings of International Falk Symposium, Molecular and Cell Biology of Liver Fibrogenesis, MarburgGermany, Jan 22–23, 1992, A M Gressner, G Ramadori, et al. Kluwer Academic Publishers, LancasterEngland, 85–98
   Google Scholar
• Chojkier M, Brenner D. Therapeutic strategies for hepatic fibrosis. Hepatology 1988; 8: 176–82
   PubMed Web of Science ®Google Scholar
• Zern M A, Czaja M J, Weiner F R. The use of molecular hybridization techniques as tools to evaluate hepatic fibrogenesis. Connective tissue in health and disease, M Rojkind. CRC Press, Boca Raton, FL 1990; Vol. 1: 99–122
   Google Scholar
• Geerts A, Bleser P D, Niki T, et al (1993) Activation of fat-storing cells and different expression of extracellular matrix mRNA. Abstracts for Falk Symposium 71, Fat-storing Cells and Liver Fibrosis. July 1–3, 1993. FlorenceItaly, 17
   Google Scholar
• Davis B H (1993) Fat storing cells and vitamin A metabolism: modulation of collagen synthesis. Abstracts for Falk Symposium 71, Fat-storing Cells and Liver Fibrosis. July 1–3, 1993. FlorenceItaly, 15
   Google Scholar
• Okuno M, Muto Y, Moriwaki H, et al. Inhibitory effect of acyclic retinoid (polyprenoic acid) on hepatic fibrosis in CC14-treated rats. Gastroenterol Jpn 1990; 25: 223–9
   PubMedGoogle Scholar
• Bosma A, Seifert W F, Wilson J H, et al. Chronic administration of ethanol with high vitamin A supplementation in a liquid diet to rats does not cause liver fibrosis. I. Morphological observations. J Hepatol 1991; 13: 240–8
   PubMed Web of Science ®Google Scholar
• Seifert W F, Broma A, Hendriks H F, et al. Chronic administration of ethanol with high vitamin A supplementation in a liquid diet to rats does not cause liver fibrosis. II. Biochemical observation. J Hepatol 1991; 13: 249–55
   PubMed Web of Science ®Google Scholar
• Margis R, Pinheiro-Margis M, da Silva L C, Borojevic R. Effects of retinol on proliferation, cell adherence and extracellular matrix synthesis in a liver myofibroblast or lipocyte cell line (GRX). Int J Exp Pathol 1992; 73: 125–35
   PubMed Web of Science ®Google Scholar
• Hoofnagle J H, Di Bisceglie A M, Shindo M. Antiviral therapy of hepatitis C–present and future. J Hepatol 1993; 17: S130–6, Suppl 3
   PubMed Web of Science ®Google Scholar
• Janssen H LA, Schahn S W, Berk L, et al. Repeated courses of a-interferon for treatment of chronic hepatitis type B. J Hepatol 1993; 17: S47–51, Suppl 3
   Web of Science ®Google Scholar
• Schlam S W. Treatment of chronic viral hepatitis anno 1990. Scand J Gastroenterol 1990; 25: 111–8, Suppl 178
   Web of Science ®Google Scholar
• Lisker-Melman M, Peters M, Ambrus J L, . Effect of recombinant human γ-interferon therapy on immune function in patients with chronic type B hepatitis. Viral hepatitis and liver diseases, A J Zuckerman, et al. Alan R. Liss. Inc., New York 1988; 686–871
   Google Scholar
• Saez-Royuela F, Porres J, Moreno C. A, et al. High doses of recombinant α-interferon or γ-interferon for chronic hepatitis C: a randomized, controlled trial. Hepatology 1991; 13: 327–31
   PubMed Web of Science ®Google Scholar
• Rockev D C, Mather J, Gabbiani J. G, et al. Interferon gamma (IFNγ) inhibits expression of smooth muscle actin and type I collagen mRNA in rat hepatic lipocytes [abstract]. Hepatologv 1991; 14: 189A
   Web of Science ®Google Scholar
• Rockey D C, Mather J J, Jarnagiin W R, Gabbiani G, Friedman S L. Inhibition of rat hepatic lipocyte activation in culture by interferon-γ. Hepatologv 1992; 16: 776–84
   PubMed Web of Science ®Google Scholar
• Czaja M, Weiner J. F, Takahashi R. S., et al. γ-Interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology 1989; 10: 795–800
   PubMed Web of Science ®Google Scholar
• Castulla A, Prieto J. Fausto N. Transforming growth factor β and α in chronic liver disease. Effects of interferon α therapy. N Engl J Med 1991; 324: 933–40
   PubMed Web of Science ®Google Scholar
• Capra F, Casaril M, Gabrielli G B, et al. Alfa interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers. J Hepatol 1993; 18: 112–8
   PubMed Web of Science ®Google Scholar
• Clement Loreal B. O, Levavasseur F, et al. New challenges in hepatic fibrosis. J Hepatol 1993; 18: 1–4
   PubMed Web of Science ®Google Scholar
• Pihlajaniemi T, Myllylä R, Kivirikko K. Prolyl 4-hydroxylase and its role in collagen synthesis. J Hepatol 1991; 13: S2–7, Suppl 3
   PubMed Web of Science ®Google Scholar
• Hanauske-Abel H M. Prolyl 4-hydroxylase, a target enzyme for drug development, design of suppressive agents and the in vitro effects of inhibitors and proinhibitors. J Hepatol 1991; 13: S8–16, Suppl 3
   Web of Science ®Google Scholar
• Bickel M, Baader E, Brocks D G, et al. Beneficial effects of inhibitors of prolyl 4-hydroxvlase in CCl4-induced fibrosis of the liver in rats. J Hepatol 1991; 13: S26–34, Suppl 3
   PubMed Web of Science ®Google Scholar
• Böker K, Schwarting Kaule G. G., et al. Fibrosis of the liver in rats induced bv bile duct ligation, effects of inhibition of prolyl 4-hydroxylase. J Hepatol 1991; 13: S35–40, Suppl 3
   PubMed Web of Science ®Google Scholar
• Clément Chesne B. C, Satie A P, et al. Effects of the prolyl 4-hydroxylase proinhibitor HOE 077 on human and rat hepa-tocytes in primary culture. J Hepatol 1991; 13: S41–7, Suppl 3
   Web of Science ®Google Scholar
• Fujiwara Ogata K. I, Ohta Y, et al. Decreased collagen accumulation by a prolyl hydroxylase inhibitor in pig serum-induced fibrotic ral live/Hepatology 1988; 8: 804–7
   Google Scholar
• Watanabe Hirose S., Miyazaki M. A, et al. A new potent prolyl hydroxylase inhibitor P-1894B reduced collagen bundle formation in primary cultured hepatoevtes [abstract]. Hepatologv 1991; 14: 191A
   Web of Science ®Google Scholar
• Rojkind M, Kershenobich D. Effect of colchicine on collagen, albumin, and transferrin synthesis by cirrhotic rat liver slides. Biochem Biophys Acta 1975; 378: 415–23
   PubMedGoogle Scholar
• Kershenobich Vargas D. F, Garcia-Tsao G, et al. Colchicine in the treatment of cirrhosis of the liver. N Engl J Med 1988; 318: 1709–13
   PubMed Web of Science ®Google Scholar
• Jiang Z, You D Y, Wu J., et al. Monitoring of serum markers of fibrosis during CCl4-induced liver damage–effects of anti-fibrotic agents. J Hepatol 1992; 16: 282–9
   PubMed Web of Science ®Google Scholar
• Diegelmann R F. Peterkofsky B. Inhibition of collagen secretion from bone and cultured fibroblasts by microtubular disruptive drugs. Proc Natl Acad Sci USA 1972; 69: 892–6
   PubMed Web of Science ®Google Scholar
• Mansour M M, Dunn M A, Salah L A. Effect of colchicine on collagen synthesis by liver fibroblasts in murine schistosomiasis. Clin Chini Acta 1988; 177: 11–20
   PubMed Web of Science ®Google Scholar
• Tanner M S. Jackson D, Mowat AP. Hepatic collagen synthesis in rat model of cirrhosis, and its modification bv colchicine. J Pathol 1981; 135: 179–87
   PubMed Web of Science ®Google Scholar
• Jiang Z, You D Y, Wu J, (1992) A comparative study of anti-fibrotic effects of dmPGE2, colchicine and zinc sulphate on CC14-induccd liver fibrosis in rat. Proceedings of International Falk Symposium, Molecular and Cell Biology of Liver Fibrogenesis, MarburgGermany, Jan 22–23, 1992, A M Gressner, G Ramadori, et al. Kluwer Academic Publishers, LancasterEngland, 517–20
   Google Scholar
• Kershenobich D, Rojkind M, Quiroga A, et al. Effect of colchicine on lymphocyte and monocyte function and its relation to fibroblast proliferation in primary biliary cirrhosis. Hepatology 1990; 11: 205–9
   PubMed Web of Science ®Google Scholar
• Shibata J, Fujuyama S, Honda Y, Sato T. Combination therapy with ursodeoxycholic acid and colchicine for primary biliary cirrhosis. J Gastroenterol Hepatol 1992; 7: 277–82
   PubMed Web of Science ®Google Scholar
• Mizoguchi Y, Tsutsui H, Miyajima K, et al. The protective effects of prostaglandin E, in an experimental massive hepatic cell necrosis model. Hepatology 1987; 7: 1184–3
   PubMed Web of Science ®Google Scholar
• Wu J, Peng C Q. An experimental study of cytoprotective effect by prostaglandin E1 on CCl4-induced liver injury in rat (in Chinese). Chin J Digest 1989; 9: 184–5
   Google Scholar
• Guarner F. Fremont-Smith M, Prieto J. Cytoprotective effect of prostaglandins on isolated rat liver cells. Liver 1985; 5: 35–9
   PubMedGoogle Scholar
• Mihas A A. Prostaglandin E1 cytoprotection against CC14-induced necrosis in isolated rat liver cells. Res Commun Chem Path Pharmacol 1992; 75: 173–84
   PubMedGoogle Scholar
• Dlugosz J W. Korsten MA, Lieber CS. The effect of the prostaglandin analogue-misoprostol on rat liver mitochondria after chronic alcohol feeding. Life Sci 1991; 49: 969–78
   PubMed Web of Science ®Google Scholar
• Wu J, Karlsson K, Danielsson Å (1993) Enisoprost protects isolated rat hepatocytes from bromobenzene toxicity in vitro. Abstracts for Falk Symposium 71, Fat-storing Cells and Liver Fibrosis. July, 1–31993. FlorenceItaly, Abstract 19
   Google Scholar
• Ruwart M J, Rush B D, Friedle N M, et al. 16,16-dimethyl prostaglandin ET partially prevents necrosis due to aflatoxin in rats. Gastroenterology 1982; 82: 1167
   Web of Science ®Google Scholar
• Stachura J, Tarnawski A, Szezudrawa J, et al. Cytoprotcctive effect of 16,16-dimethyl prostaglandin E2 and some drugs on an acute galactosamine induced liver damage in rat. Folia His-tochem Cytochem 1980; 9: 311–8
   Google Scholar
• Kurebayashi Y, Honda Y. Protection by 16,16-dimethyl prostaglandin E2 and dibutyryl cyclic AMP against complement-mediated hepatic necrosis in rats. Hepatology 1991; 14: 545–50
   PubMed Web of Science ®Google Scholar
• Bursch W, Taper H S, Somer M P, et al. Histochemical and biochemical studies on the effect of the prostacyclin derivative, iloprost on CCl4-induced lipid peroxidation in rat liver and its significance for hepatoevtoprotection. Hepatology 1989; 9: 830–8
   PubMed Web of Science ®Google Scholar
• Nasseri-Sina P, Fawthrop D J, Wilson J, Boobis A R, et al. Cytoprotection by iloprost against paracetamol-induced toxicity in hamster isolated hepatocytes. Br J Pharmacol 1992; 105: 417–23
   PubMed Web of Science ®Google Scholar
• Ruwart M J, Rush B D, Snyder K F, et al. 16,16-dimethyl prostaglandin E2 delays collagen formation in nutritional injury in rat liver. Hepatology 1988; 8: 61–4
   PubMed Web of Science ®Google Scholar
• Peters K M, Snyder K F, Rush B D, et al. 16,16-dimethyl prostaglandin E2 decreases the formation of collagen in fibrosis rat liver slides. Prostaglandins 1989; 37: 445–56
   PubMedGoogle Scholar
• Degli E, Sposti S, He O, Frizell E, et al. The multifaceted effects of enisoprost, a prostaglandin E1 analogue, in inhibiting hepatic fibrosis [abstract]. Hepatology 1991; 14: 113A
   Web of Science ®Google Scholar
• Beno D WA, Epinal R, Edelstein B M, et al. Administration of prostaglandin E1 analogue reduces rat hepatic and Ito cell collagen gene expression and collagen accumulation after bile duct ligation injury. Hepatology 1993; 17: 707–14
   PubMed Web of Science ®Google Scholar
• Robert P, Felen F, Gueant J L, et al. Treatment of patients with alcoholic cirrhosis with a synthetic prostaglandin E2: enprostil [abstract]. Proceedings of World Congress of Gastroenterology. Aug, 26–311990. SydneyAustralia, PD1116
   Google Scholar
• Clark J G, Kostal K M, Marino B AI. Modulation of collagen production following bleomycin induced pulmonary fibrosis in hamsters. Presence of a factor in lung that increases fibroblast prostaglandin E2 and cAMP and suppresses fibroblast proliferation and collagen production. J Biol Chem 1982; 257: 8089–105
   Web of Science ®Google Scholar
• Bhatnager R, Schade U, Rietschel E T, et al. Involvement of prostaglandin E and adenosis 3′,5′-monophosphate in lipo-polysaccharide stimulated collagenase by rat Kupffer cells. Eur J Biochem 1982; 125: 125–30
   PubMedGoogle Scholar
• Abecassis M, Falk J A, Makowka L, et al. Cytoprotective effect of 16,16-dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction monocyte/ macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest 1987; 80: 881–9
   PubMed Web of Science ®Google Scholar
• Tsukada K, Katoh H, Iga Y, et al. Prostaglandin E1 enhances hepatic vascular bed in 70% hepatectomized dog. Gastroenterol Jpn 1992; 27: 341–7
   PubMedGoogle Scholar
• Sugimoto T (1983) Malotilate: an overview Hepatotrophic agent malotilate. Proceedings of a symposium on malotilate held at the 7th World Congress of Gastroenterology, Stockholm, June, 151982, T Oda, N Trygstrup. Excerpta Medica, Amsterdam, 1–7
   Google Scholar
• Suzuki H, Ichida F, Takino T, (1983) Therapeutic effects of malotilate on chronic hepatitis and liver cirrhosis: a double blind, controlled multicenter trial. Hepatotrophic agent malotilate. Proceedings of a symposium on malotilate held at the 7th World Congress of Gastroenterology, Stockholm, June, 151982, T Oda, N Trygstrup, et al. Excerpta Medica, Amsterdam, 54–68
   Google Scholar
• Igarashi S, Hatahara T, Nagai Y, et al. Anti-fibrotic effect of malotilate on liver fibrosis induced by carbon tetrachloride in rats. Jpn J Exp Med 1986; 56: 235–45
   PubMedGoogle Scholar
• Ala-Kokko L, Stenbäck F, Ryhanen L. Preventive effect of malotilate on dimethylnitrosamine-induced liver fibrosis in the rat. J Lab Clin Med 1989; 113: 177–83
   PubMed Web of Science ®Google Scholar
• Takase S, Takasa A, Yasuhara M, et al. Effects of malotilate treatment on the serum markers of hepatic fibrogenesis in liver cirrhosis. Gastroenterol Jpn 1988; 23: 639–45
   PubMedGoogle Scholar
• A European Multicentre Study Group. The results of a randomized double blind controlled trial evaluating malotilate in primary biliary cirrhosis. J Hepatol 1993; 17: 227–35
   PubMed Web of Science ®Google Scholar
• Lieber C S, De Carli L M, Mak K M, et al. Attenuations of alcohol-induced hepatic fibrosis by polyunsaturated lecithin. Hepatology 1990; 12: 1390–8
   PubMed Web of Science ®Google Scholar
• Li J-J, Kim C I, Leo M A, et al. Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by stimulating collagenase activity in cultured lipocytes. Hepatology 1992; 15: 373–81
   PubMed Web of Science ®Google Scholar
• Friedman S L. ‘Cuts both ways’: collagenases, lipocyte activation and polyunsaturated lecithin. Hepatology 1992; 15: 549–51
   PubMed Web of Science ®Google Scholar
• Friedman S L. The cellular basis of hepatic fibrosis, mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828–35
   PubMed Web of Science ®Google Scholar
• Schuppan D. Connective tissue polypeptides in serum as parameters to monitor anti-fibrotic treatment fibrogenesis. J Hepatol 1991; 13: S17–25, Suppl3
   Web of Science ®Google Scholar
• Houglum K, Brenner D A, Ckojkier M. d-α-Tocopherol inhibits collagen α1(I) gene expression in cultured human fibroblasts, modulation of constitutive collagen gene expression by lipid peroxidation. J Clin Invest 1991; 87: 2230–5
   PubMed Web of Science ®Google Scholar
• Parola M, Muraca R, Dianzani I, et al. Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver. FEBS Lett 1992; 308: 267–70
   PubMed Web of Science ®Google Scholar
• Stavinoha M W, Soloway R D. Current therapy of chronic liver disease. Drugs 1990; 39: 814–40
   PubMed Web of Science ®Google Scholar
• Ohmae H, Tanaka M, Nara T, et al. Serologic and ultrasonographic parameters of praziquantel treatment of hepatic fibrosis in Schistosoma japonicum infection. Am J Trop Med Hyg 1991; 45: 350–9
   PubMed Web of Science ®Google Scholar
• Doehring-Schwerdtfeger E, Abdel-Rahim I M, Kardorff R, et al. Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity twenty-three months after treatment with praziquantel. Am J Trop Med Hyg 1992; 46: 409–15
   PubMed Web of Science ®Google Scholar
• Stenbäck F, Saarni H U, Rautio A, et al. Reversibility of rat liver cirrhosis by medroxyprogesterone acetate. Toxicol Path 1989; 17: 38–45
   PubMed Web of Science ®Google Scholar
• Hernandez-Munoz R, Diaz-Munoz M, Suarez J, et al. Adenosine partially prevents cirrhosis by carbon tetrachloride in rats. Hepatology 1991; 12: 242–8
   Web of Science ®Google Scholar
• Ferenci P, Dragosics B, Dittrich H, et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 1989; 9: 105–13
   PubMed Web of Science ®Google Scholar
• Corrales F, Giménez A, Alvarez L, Caballeria J, et al. S-adenosyl-L-methionine treatment prevents carbon tetrachlo-ride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injury. Hepatology 1992; 16: 1022–7
   PubMed Web of Science ®Google Scholar
• Caballeria J, Giménez A, Pares A, et al (1993) Experimental data on the effect of ademethionine (SAMe) in liver fibrosis. Abstract for International Falk Symposium No. 71, Fat Storing Cells and Liver Fibrosis. July, 1–31993. Florence, Italy, 45
   Google Scholar
• Camps J, Constanti C, Folch J, (1992) Effects of zinc on hepatic lipid peroxidation, metallothioneins and fibrogenesis in carbon tetrachloride-treated rats. Proceedings of International Falk Symposium, Molecular and Cell Biology of Liver Fibrogenesis, MarburgGermany, Jan, 22–231992, A M Gressner, G Ramadori, et al. Kluwer Academic Publishers, LancasterEngland, 524–6
   Google Scholar
• Giménez A, Caballeria J, Parés A, et al. Influence of dietary zinc on hepatic collagen and prolyl hydroxylase activity in alcoholic rats. Hepatology 1992; 16: 815–9
   PubMed Web of Science ®Google Scholar